|
Front Cover |
1 |
|
|
The Human Genome |
4 |
|
|
Copyright Page |
5 |
|
|
Contents |
8 |
|
|
Acknowledgments |
12 |
|
|
Prologue: The Answer in a Nutshell |
14 |
|
|
SECTION I: HOW GENES SPECIFY A TRAIT |
16 |
|
|
Chapter 1 The Basics of Heredity: How Traits Are Passed Along in Families |
18 |
|
|
1.1 Mendel's Laws |
19 |
|
|
1.2 Selection: Artificial, Natural, and Sexual |
27 |
|
|
1.3 Human Genetic Diversity |
30 |
|
|
1.4 Human Dominant Inheritance |
31 |
|
|
1.5 Human Recessive Inheritance |
34 |
|
|
1.6 Complementation |
42 |
|
|
1.7 Epistasis and Pleiotropy |
46 |
|
|
1.8 Complex Syndromes |
47 |
|
|
1.9 One Man's Disease Is Another Man's Trait |
49 |
|
|
Chapter 2 The Double Helix: How Cells Preserve Genetic Information |
56 |
|
|
2.1 Inside the Cell |
57 |
|
|
2.2 DNA: The Repository of Genetic Information |
59 |
|
|
2.3 DNA and the Double Helix |
62 |
|
|
2.4 DNA Replication |
65 |
|
|
2.5 Chromatin |
71 |
|
|
2.6 What Are Chromosomes? |
72 |
|
|
2.7 Euchromatin and Heterochromatin |
79 |
|
|
2.8 The Mitochondrial Chromosome: The "Other Genome" in the Human Genome |
80 |
|
|
2.9 DNA in vitro |
82 |
|
|
SECTION II: HOW GENES FUNCTION |
96 |
|
|
Chapter 3 The Central Dogma of Molecular Biology: How Cells Orchestrate the Use of Genetic Information |
98 |
|
|
3.1 What Is RNA? |
99 |
|
|
3.2 What Is RNA For? |
102 |
|
|
3.3 Transcription of RNA |
104 |
|
|
3.4 Orchestrating Expression |
106 |
|
|
3.5 Monitoring Gene Expression |
110 |
|
|
3.6 Interaction of Transcription Factors |
113 |
|
|
3.7 Inducible Genes |
117 |
|
|
3.8 Epigenetic Control of Gene Expression |
119 |
|
|
3.9 What Constitutes Normal? |
121 |
|
|
Chapter 4 The Genetic Code: How the Cell Makes Proteins from Genetic Information Encoded in mRNA Molecules |
130 |
|
|
4.1 The Genetic Code |
131 |
|
|
4.2 Moving Things In and Out of the Nucleus |
134 |
|
|
4.3 The Central Dogma of Molecular Biology |
135 |
|
|
4.4 Translation |
135 |
|
|
4.5 Messenger RNA Structure |
137 |
|
|
4.6 Splicing |
139 |
|
|
4.7 Modular Genes |
143 |
|
|
4.8 What Are Proteins? |
145 |
|
|
4.9 Gene Products and Development |
150 |
|
|
Chapter 5 We Are All Mutants: How Mutation Alters Function |
158 |
|
|
5.1 What Is a Mutation? |
159 |
|
|
5.2 The Process of Mutation |
162 |
|
|
5.3 How We Detect Mutations |
168 |
|
|
5.4 Basic Mutations |
174 |
|
|
5.5 Mutations in DNA Sequences that Regulate Gene Expression |
181 |
|
|
5.6 Copy Number Variation: Too Much or Too Little of a Good Thing |
182 |
|
|
5.7 Expanded Repeat Traits |
184 |
|
|
5.8 The Male Biological Clock |
195 |
|
|
5.9 Mutation Target Size |
195 |
|
|
5.10 Absent Essentials and Monkey Wrenches |
198 |
|
|
SECTION III: HOW CHROMOSOMES MOVE |
212 |
|
|
Chapter 6 Mitosis and Meiosis: How Cells Move Your Genes Around |
214 |
|
|
6.1 The Cell Cycle |
215 |
|
|
6.2 Mitosis |
216 |
|
|
6.3 Gametogenesis: What Is Meiosis Trying to Accomplish? |
222 |
|
|
6.4 Meiosis in Detail |
226 |
|
|
6.5 Mechanisms of Chromosome Pairing in Meiosis |
232 |
|
|
6.6 The Chromosomal Basis of Heredity |
234 |
|
|
6.7 Aneuploidy: When Too Much or Too Little Counts |
239 |
|
|
6.8 Uniparental Disomy |
245 |
|
|
6.9 Partial Aneuploidies |
251 |
|
|
6.10 The Female Biological Clock |
253 |
|
|
Appendix 6.1 Failed Meiotic Segregation (Nondisjunction) as Proof of the Chromosome Theory of Heredity |
255 |
|
|
Chapter 7 The Odd Couple: How the X and Y Chromosomes Break the Rules |
262 |
|
|
7.1 Passing the X and Y Chromosomes between Generations |
263 |
|
|
7.2 How Humans Cope with the Difference in Number of Sex Chromosomes between Males and Females |
264 |
|
|
7.3 How X Inactivation Works |
265 |
|
|
7.4 Skewed X Inactivation – When Most Cells Inactivate the Same X |
266 |
|
|
7.5 Genes that Escape X-Inactivation |
270 |
|
|
7.6 Reactivation of the Inactive X Chromosome in the Female Germline |
270 |
|
|
7.7 X Chromosome Inactivation During Male Meiosis |
270 |
|
|
7.8 X Inactivation and the Phenotypes of Sex Chromosome Aneuploidy |
272 |
|
|
7.9 The Structure of the Human Y Chromosome |
274 |
|
|
7.10 X-Linked Recessive Inheritance |
277 |
|
|
7.11 X-Linked Dominant Inheritance |
280 |
|
|
SECTION IV: HOW GENES CONTRIBUTE TO COMPLEX TRAITS |
286 |
|
|
Chapter 8 Sex Determination: How Genes Determine a Developmental Choice |
288 |
|
|
8.1 Sex as a Complex Developmental Characteristic |
289 |
|
|
8.2 What Do the X and Y Chromosomes Have to Do With Sex? |
293 |
|
|
8.3 SRY on the Y: The Genetic Determinant of Male Sexual Differentiation |
294 |
|
|
8.4 The Role of Hormones in Early Development |
297 |
|
|
8.5 Androgen Receptor on the X: Another Step in the Sexual Differentiation Pathway |
300 |
|
|
8.6 Genetics of Gender Identification |
302 |
|
|
8.7 Genetics of Sexual Orientation |
303 |
|
|
Chapter 9 Complexity: How Traits Can Result from Combinations of Factors |
314 |
|
|
9.1 Digenic Diallelic Inheritance |
315 |
|
|
9.2 Digenic Triallelic Inheritance |
319 |
|
|
9.3 Multifactorial Inheritance |
320 |
|
|
9.4 Quantitative Traits |
322 |
|
|
9.5 Additive Effects and Thresholds |
324 |
|
|
9.6 Is It Genetic? |
325 |
|
|
9.7 Genes and Environment: Inducible Traits |
327 |
|
|
9.8 Genes and Environment: Infectious Disease |
330 |
|
|
9.9 Phenocopies |
334 |
|
|
9.10 Genotypic Compatibility: Whose Genome Matters? |
337 |
|
|
9.11 Phenotypic Heterogeneity: One Gene, Many Traits |
339 |
|
|
9.12 Genotypic and Phenotypic Heterogeneity |
340 |
|
|
9.13 Variable Expressivity |
343 |
|
|
9.14 Phenotypic Modifiers |
344 |
|
|
9.15 Biochemical Pathways Underlying Complexity |
346 |
|
|
9.16 Behavioral Genetics |
349 |
|
|
9.17 Genes Expression: Another Level of Complexity |
352 |
|
|
Chapter 10 The Multiple-Hit Hypothesis: How Genes Play a Role in Cancer |
358 |
|
|
10.1 The War on Cancer |
359 |
|
|
10.2 Cancer as a Defect in Regulation of the Cell Cycle |
360 |
|
|
10.3 Cancer as a Genetic Disease |
361 |
|
|
10.4 Cancer and the Environment |
363 |
|
|
10.5 Tumor Suppressor Genes and the Two-Hit Hypothesis |
363 |
|
|
10.6 Cell-Type Specificity of Tumor Suppressor Gene Defects |
367 |
|
|
10.7 The Multi-Hit Hypothesis |
368 |
|
|
10.8 The Activation of Proto-Oncogenes and the Role of Oncogenes in Promoting Cancer |
370 |
|
|
10.9 Defects in DNA Repair |
372 |
|
|
10.10 Personalized Medicine |
373 |
|
|
10.11 Cancer Biomarkers |
376 |
|
|
SECTION V: HOW GENES ARE FOUND |
382 |
|
|
Chapter 11 The Gene Hunt: How Genetic Maps Are Built and Used |
384 |
|
|
11.1 What Is a Genetic Map? |
385 |
|
|
11.2 What Is a Genetic Marker? |
387 |
|
|
11.3 Finding Genes before There Were Maps |
393 |
|
|
11.4 Defining the Thing to Be Mapped |
395 |
|
|
11.5 Recombination as a Measure of Genetic Distance |
397 |
|
|
11.6 Physical Maps and Physical Distances |
403 |
|
|
11.7 How Did They Build Genetic Maps? |
408 |
|
|
11.8 After the Map: What Came Next? |
411 |
|
|
Chapter 12 The Human Genome: How the Sequence Enables Genome-wide Studies |
420 |
|
|
12.1 The Human Genome Project |
421 |
|
|
12.2 The Human Genome Sequence |
431 |
|
|
12.3 The Other Genome Projects |
433 |
|
|
12.4 The Genes in the Human Genome |
435 |
|
|
12.5 Human Genome Variation |
443 |
|
|
12.6 Genome-wide Technologies |
447 |
|
|
12.7 Genome-wide Association |
448 |
|
|
12.8 Allele Sharing and Sib Pair Analysis |
454 |
|
|
12.9 Copy Number Variation and Gene Dosage |
455 |
|
|
12.10 Whole Genome Sequencing |
458 |
|
|
SECTION VI: HOW GENES PLAY A ROLE IN TESTING AND TREATMENT |
468 |
|
|
Chapter 13 Genetic Testing and Screening: How Genotyping Can Offer Important Insights |
470 |
|
|
13.1 What Is Medical Genetics? |
472 |
|
|
13.2 Screening vs. Testing |
474 |
|
|
13.3 Preimplantation Genetic Screening |
476 |
|
|
13.4 Prenatal Diagnosis During the First Trimester |
478 |
|
|
13.5 Prenatal Diagnosis During the Second Trimester |
480 |
|
|
13.6 Amniocentesis and Chorionic Villus Sampling |
481 |
|
|
13.7 Analysis of Fetal Cells |
484 |
|
|
13.8 Sex Selection |
488 |
|
|
13.9 Newborn Screening |
489 |
|
|
13.10 Adult Genetic Screening and Testing |
490 |
|
|
13.11 Ethical, Legal, and Social Issues |
495 |
|
|
Chapter 14 Magic Bullets: How Gene-based Therapies Personalize Medicine |
502 |
|
|
14.1 Replacing a Lost Gene or Funtion – The RPE Story |
503 |
|
|
14.2 Replacing a Lost Gene – ADA Deficiency |
507 |
|
|
14.3 Targeting Downstream Disease Pathology |
508 |
|
|
14.4 Suppressing the Unwanted Genotype – Use of siRNAs and miRNAs |
510 |
|
|
14.5 Gene Supplement Therapy – More of the Same |
512 |
|
|
14.6 Strategies for Cancer Therapy |
513 |
|
|
14.7 Gene-based Therapy Instead of Gene Therapy |
515 |
|
|
14.8 Delivering Gene Therapy |
517 |
|
|
14.9 Do We Have to Treat the Whole Body? |
518 |
|
|
14.10 What Are the Biggest Problems with Gene Therapy? |
520 |
|
|
14.11 So, Whom Do We Treat? |
521 |
|
|
Chapter 15 Fears, Faith, and Fantasies: How the Past and Present Shape the Future of Genomic Medicine |
528 |
|
|
15.1 Fears – A Tale of Eugenics |
529 |
|
|
15.2 Faith – A Tale of Ethical, Legal, and Social Advances |
533 |
|
|
15.3 Fantasies – A Tale of Our Genetic Future |
537 |
|
|
Answers to Study Questions |
542 |
|
|
Glossary |
568 |
|
|
A |
568 |
|
|
B |
569 |
|
|
C |
570 |
|
|
D |
573 |
|
|
E |
574 |
|
|
F |
575 |
|
|
G |
575 |
|
|
H |
576 |
|
|
I |
578 |
|
|
J |
579 |
|
|
K |
579 |
|
|
L |
579 |
|
|
M |
580 |
|
|
N |
581 |
|
|
O |
582 |
|
|
P |
582 |
|
|
Q |
584 |
|
|
R |
584 |
|
|
S |
586 |
|
|
T |
587 |
|
|
U |
589 |
|
|
V |
589 |
|
|
W |
589 |
|
|
X |
589 |
|
|
Z |
589 |
|
|
Index |
590 |
|
|
A |
590 |
|
|
B |
590 |
|
|
C |
590 |
|
|
D |
591 |
|
|
E |
592 |
|
|
F |
593 |
|
|
G |
593 |
|
|
H |
594 |
|
|
I |
594 |
|
|
J |
595 |
|
|
K |
595 |
|
|
L |
595 |
|
|
M |
595 |
|
|
N |
596 |
|
|
O |
596 |
|
|
P |
596 |
|
|
Q |
597 |
|
|
R |
597 |
|
|
S |
598 |
|
|
T |
598 |
|
|
U |
599 |
|
|
V |
599 |
|
|
W |
599 |
|
|
X |
599 |
|
|
Y |
600 |
|
|
Z |
600 |
|